News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
281,704 Results
Type
Article (14900)
Company Profile (299)
Press Release (266499)
Multimedia
Podcasts (78)
Webinars (11)
Section
Business (79873)
Career Advice (162)
Deals (13343)
Drug Delivery (39)
Drug Development (50703)
Employer Resources (31)
FDA (5837)
Job Trends (5172)
News (145127)
Policy (10076)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (920)
Accelerated approval (19)
Adcomms (14)
Allergies (81)
Alliances (21763)
ALS (125)
Alzheimer's disease (1032)
Antibody-drug conjugate (ADC) (241)
Approvals (6032)
Artificial intelligence (259)
Autoimmune disease (113)
Automation (9)
Bankruptcy (105)
Best Places to Work (4563)
BIOSECURE Act (6)
Biosimilars (100)
Biotechnology (230)
Bladder cancer (101)
Brain cancer (45)
Breast cancer (344)
Cancer (3130)
Cardiovascular disease (237)
Career advice (147)
Career pathing (7)
CAR-T (218)
CDC (5)
Cell therapy (564)
Cervical cancer (14)
Clinical research (43675)
Collaboration (1151)
Company closure (2)
Compensation (596)
Complete response letters (39)
COVID-19 (1101)
CRISPR (86)
C-suite (553)
Cystic fibrosis (112)
Data (4324)
Denatured (15)
Depression (92)
Diabetes (255)
Diagnostics (1380)
Digital health (10)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (188)
Drug pricing (48)
Drug shortages (3)
Duchenne muscular dystrophy (215)
Earnings (31671)
Editorial (25)
Employer branding (4)
Employer resources (29)
Events (51693)
Executive appointments (622)
FDA (7590)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (22)
Funding (981)
Gene editing (182)
Generative AI (21)
Gene therapy (489)
GLP-1 (504)
Government (1147)
Grass and pollen (3)
Guidances (166)
Healthcare (6616)
HIV (18)
Huntington's disease (43)
IgA nephropathy (74)
Immunology and inflammation (190)
Immuno-oncology (40)
Indications (66)
Infectious disease (1206)
Inflammatory bowel disease (156)
Inflation Reduction Act (10)
Influenza (38)
Intellectual property (166)
Interviews (18)
IPO (7350)
IRA (12)
Job creations (869)
Job search strategy (129)
JPM (40)
Kidney cancer (9)
Labor market (22)
Layoffs (243)
Leadership (9)
Legal (1404)
Liver cancer (41)
Longevity (11)
Lung cancer (420)
Lymphoma (249)
Machine learning (24)
Management (7)
Manufacturing (376)
MASH (130)
Medical device (2679)
Medtech (2688)
Mergers & acquisitions (6617)
Metabolic disorders (725)
Multiple sclerosis (104)
NASH (13)
Neurodegenerative disease (231)
Neuropsychiatric disorders (70)
Neuroscience (1954)
Neurotech (1)
NextGen: Class of 2026 (2040)
Non-profit (866)
Now hiring (30)
Obesity (329)
Opinion (125)
Ovarian cancer (131)
Pain (103)
Pancreatic cancer (161)
Parkinson's disease (232)
Partnered (12)
Patents (301)
Patient recruitment (329)
Peanut (43)
People (26660)
Pharmaceutical (44)
Pharmacy benefit managers (6)
Phase 1 (15476)
Phase 2 (20292)
Phase 3 (12823)
Pipeline (3259)
Policy (90)
Postmarket research (853)
Preclinical (6535)
Press Release (30)
Prostate cancer (145)
Psychedelics (50)
Radiopharmaceuticals (238)
Rare diseases (651)
Real estate (1448)
Recruiting (12)
Regulatory (9898)
Reports (19)
Research institute (971)
Resumes & cover letters (18)
Rett syndrome (24)
RNA editing (21)
RSV (16)
Schizophrenia (123)
Series A (182)
Series B (136)
Service/supplier (1)
Sickle cell disease (77)
Special edition (18)
Spinal muscular atrophy (119)
Sponsored (15)
Startups (2005)
State (1)
Stomach cancer (5)
Supply chain (32)
Tariffs (18)
The Weekly (62)
Vaccines (334)
Venture capital (69)
Weight loss (173)
Women's health (25)
Worklife (2)
Date
Today (44)
Last 7 days (347)
Last 30 days (1157)
Last 365 days (17839)
2026 (1694)
2025 (18098)
2024 (20552)
2023 (22428)
2022 (26829)
2021 (27819)
2020 (23367)
2019 (16247)
2018 (11744)
2017 (13749)
2016 (11841)
2015 (14349)
2014 (10396)
2013 (7487)
2012 (7532)
2011 (7615)
2010 (7428)
Location
Africa (154)
Alabama (65)
Alaska (2)
Arizona (71)
Arkansas (6)
Asia (18296)
Australia (3111)
California (7078)
Canada (1839)
China (774)
Colorado (246)
Connecticut (252)
Delaware (235)
Europe (39174)
Florida (903)
Georgia (209)
Hawaii (2)
Idaho (17)
Illinois (395)
India (35)
Indiana (161)
Iowa (8)
Japan (223)
Kansas (80)
Kentucky (9)
Louisiana (7)
Maine (11)
Maryland (736)
Massachusetts (5586)
Michigan (110)
Minnesota (247)
Mississippi (3)
Missouri (32)
Montana (16)
Nebraska (5)
Nevada (32)
New Hampshire (21)
New Jersey (1648)
New Mexico (13)
New York (1763)
North Carolina (827)
North Dakota (6)
Northern California (3476)
Ohio (177)
Oklahoma (11)
Oregon (24)
Pennsylvania (1278)
Puerto Rico (9)
Rhode Island (25)
South America (215)
South Carolina (9)
Southern California (2808)
Tennessee (40)
Texas (906)
United States (23345)
Utah (96)
Virginia (136)
Washington D.C. (37)
Washington State (592)
West Virginia (1)
Wisconsin (45)
281,704 Results for "spero therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Spero Therapeutics Announces Presentations on Tebipenem Hbr at IDWeek
October 15, 2025
·
5 min read
Press Releases
Spero Therapeutics Announces Third Quarter 2025 Operating Results and Provides a Business Update
November 14, 2025
·
8 min read
Press Releases
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - November 28, 2025
December 1, 2025
·
1 min read
Press Releases
Spero Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update on November 13, 2025
November 4, 2025
·
1 min read
Press Releases
Spero Announces NDA Resubmission of Tebipenem HBr by GSK to the FDA for the Treatment of Complicated Urinary Tract Infections, Including Pyelonephritis
December 22, 2025
·
3 min read
Press Releases
Spero Therapeutics Announces Second Quarter 2025 Operating Results and Provides a Business Update
August 12, 2025
·
10 min read
Layoffs
Spero Therapeutics to Lay Off 39% of Employees
Following disappointing results for an antibiotic candidate whose development program is now being suspended, Spero Therapeutics is looking to extend its cash runway while it focuses on other assets in its pipeline.
October 30, 2024
·
1 min read
·
Angela Gabriel
Press Releases
Spero Therapeutics to Report Second Quarter 2025 Financial Results and Provide Business Update on Tuesday, August 12, 2025
August 6, 2025
·
1 min read
Press Releases
Spero Therapeutics Appoints Esther Rajavelu as President and Chief Executive Officer
April 28, 2025
·
4 min read
Press Releases
Spero Therapeutics Announces First Quarter 2025 Operating Results and Provides a Business Update
May 14, 2025
·
8 min read
1 of 28,171
Next
